Article

Hypofractionation in glioblastoma multiforme

{ "0" : "Department of Radiotherapy, Academic Medical Centre, University of Amsterdam, P.0. Box 22700, 1100 DE Amsterdam, The Netherlands" , "1" : "Departmentt of Neurosurgery, Academic Medical Centre, University of Amsterdam, P.0. Box 22700, 1100 DE Amsterdam, The Netherlands" , "3" : "Glioblastoma multiforme" , "4" : "Radiotherapy" , "5" : "Hypofractionation"}
Radiotherapy and Oncology DOI:10.1016/S0167-8140(99)00183-8 pp.143-148

ABSTRACT Purpose: To compare conventional fractionation with hypofractionation in patients with a glioblastoma multiforme. Endpoints of the analysis are overall survival and palliative effect.Materials and methods: From 1988 to 1998, 155 patients with pathologically confirmed glioblastoma multiforme were prospectively analysed. Patients without irradiation and patients receiving an interstitial boost were excluded from this analysis. Three different radiation schemes were used in subsequent periods; 33×2, 8×5 and 4×7 Gy. In the last 5 years a scheme of 4×7 Gy conformal irradiation was given to poor prognosis patients. The more favourable group received the conventionally fractionated scheme up to 66 Gy.Results: Median survival was 7, 5.6 and 6.6 months for the 33×2, 8×5 and 4×7 Gy, respectively. In general, patients in the hypofractionation group had far worse prognostic factors compared with patients treated with the conventional scheme. The period of neurological improvement or stabilisation was similar between the 4×7 and 33×2 Gy group.Conclusion: An extreme hypofractionation scheme of 4×7 Gy conformal irradiation in poor prognostic glioblastoma patients is well tolerated, convenient for the patient and provides equal palliation without negative effects on survival compared with conventional fractionation.

0 0
 · 
0 Bookmarks
 · 
16 Views

Keywords

33×2 Gy group.Conclusion
 
4×7 Gy conformal irradiation
 
66 Gy.Results
 
convenient
 
conventional scheme
 
conventionally fractionated scheme
 
different radiation schemes
 
Endpoints
 
extreme hypofractionation scheme
 
favourable group
 
glioblastoma multiforme
 
hypofractionation group
 
last 5 years
 
negative effects
 
palliative effect.Materials
 
patients
 
poor prognosis patients
 
poor prognostic glioblastoma patients
 
stabilisation
 
subsequent periods
 

Maarten C C M Hulshof